HRT Financial
LENZ icon

HRT Financial’s LENZ Therapeutics LENZ Stock Holding History

HRT Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-145,506
Closed -$1.33M – 5550
2026
Q1 		$1.33M Sell
145,506
-25,777
-15% -$362K ﹤0.01% 1883
2025
Q4 		$2.74M Buy
171,283
+141,974
+484% +$4.14M 0.01% 1105
2025
Q3 		$1.36M Buy
+29,309
New +$1.08M 0.01% 1360
2023
Q2 		– Sell
-2,785
Closed -$47K – 3419
2023
Q1 		$47K Buy
+2,785
New +$45K ﹤0.01% 2127

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

HRT Financial's LENZ Position: Q2 2026 in Review

HRT Financial sold out of LENZ Therapeutics (LENZ) in Q2 2026, closing a stake of 145,506 shares — an estimated $1.33M sold.

HRT Financial first reported a position in LENZ in Q1 2023 and held it in 4 quarters. The position peaked at $2.74M in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • HRT Financial reported no remaining LENZ Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 145,506 LENZ Therapeutics shares in Q2 2026, an estimated $1.33M.
  • HRT Financial first reported a position in LENZ Therapeutics in Q1 2023 and held it in 4 quarters.
  • HRT Financial's LENZ Therapeutics position peaked at $2.74M in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.